Product Information

DORZOLAMIDE HCL 2% EYE DROPS is a generic product labeled by Bausch & Lomb Incorporated, priced at $0.8314 per ML under NDC 24208048510. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Jun 25, 2009. Its Orange Book therapeutic-equivalence code is AT.

DORZOLAMIDE HCL 2% EYE DROPS

Dorzolamide HCl
$0.8314per ML

Strength

20 mg/mL

NDC

24208048510

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

8/19/2026

Active Ingredients

DORZOLAMIDE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA090143

FDA Approved

6/25/2009

TE Code

AT

On Market Since

6/25/2009

Pharmacological Classes

Carbonic Anhydrase Inhibitor
Carbonic Anhydrase Inhibitors

Price Statistics

The NADAC for DORZOLAMIDE HCL 2% EYE DROPS has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 46.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.8314 per ML
All-time high$1.8762 (May 13, 2020)
All-time low$0.8212 (Jul 22, 2026)
52-week high$1.0745
52-week low$0.8212
Median price$1.3461
Average price$1.3428
Largest weekly change+42.1% (Sep 18, 2024)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+1.2%

1M

+1.2%

3M

-2.8%

6M

-9.0%

1Y

-22.6%

3Y

-38.3%

5Y

-42.1%

All

-46.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dorzolamide HCl market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of DORZOLAMIDE HCL 2% EYE DROPS?

The current National Average Drug Acquisition Cost (NADAC) for DORZOLAMIDE HCL 2% EYE DROPS, manufactured by Bausch & Lomb Incorporated, is $0.8314 per ML (NDC 24208048510), effective Aug 19, 2026.

How has the price of DORZOLAMIDE HCL 2% EYE DROPS changed over time?

Over the history we have for it, the NADAC for DORZOLAMIDE HCL 2% EYE DROPS has declined 46.4%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for DORZOLAMIDE HCL 2% EYE DROPS?

Since Nov 28, 2013, the NADAC for DORZOLAMIDE HCL 2% EYE DROPS has ranged from a low of $0.8212 (Jul 22, 2026) to a high of $1.8762 (May 13, 2020), with a median of $1.3461 per ML.

Are there cheaper alternatives to DORZOLAMIDE HCL 2% EYE DROPS?

No other NADAC-published product currently shares the active ingredient and strength of DORZOLAMIDE HCL 2% EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures DORZOLAMIDE HCL 2% EYE DROPS?

DORZOLAMIDE HCL 2% EYE DROPS (NDC 24208048510) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.